Health Care/Hospital
Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer
* Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients with difficult-to-treat cancers such as triple-negative breast cancer and pancreatic cancer * Niclosamide-based oral anticancer drug project to be carried out by the new subsidiary of Hyundai Biosci...
2024-04-22 17:51
941
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
SHANGHAI, April 22, 2024 /PRNewswire/ -- Themed "Planet vs. Plastics," the 55th
Earth Day serves as a deep reminder for everyone to play a role in
environmental protection.Angel Yeast
2024-04-22 16:00
3591
AGCO Agriculture Foundation Donates $450,000 AUD to Rural Aid Australia
DULUTH, Ga., April 22, 2024 /PRNewswire/ -- The AGCO Agriculture Foundation (the "Foundation"), a private foundation with the vision to prevent and relieve hunger through sustainable agriculture development, announced a$450,000 AUD grant to Rural Aid to support farmers' mental health and wellbein...
2024-04-22 14:00
1444
GT20029 China Phase II Trial For AGA Reached Primary Endpoint
SUZHOU, China, April 21, 2024 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced thatthe China phase II clinical trial (the "Phase II Clinical Trial") of i...
2024-04-22 09:53
1730
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards
SINGAPORE, April 18, 2024 /PRNewswire/ -- Juniper Biologics
2024-04-22 09:00
1007
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards
SINGAPORE, April 22, 2024 /PRNewswire/ -- Juniper Biologics
2024-04-22 09:00
1116
BGI Genomics Leads Innovation with Inaugural Clinical Lab in Uruguay
Cutting-edge facility to serve as a beacon for preventive medicine in Latin America MONTEVIDEO, Uruguay, April 22, 2024 /PRNewswire/ -- BGI Genomics, a global leader in integrated precision medicine solutions, has established a new clinical laboratory atUruguay's Parque de las Ciencias free trad...
2024-04-22 08:27
1118
ASTRI's Wins 23 Awards Geneva Inventions Expo
Gemstones Identification Technology Earns Gold Medal with Congratulations of Jury HONG KONG, April 20, 2024 /PRNewswire/ -- The Hong Kong Applied Science and Technology Research Institute (ASTRI) has won 23 accolades at the 49th International Exhibition of Inventions Geneva, including 1 "Gold Me...
2024-04-20 16:31
1879
CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN "MAGICAL-ISR" IDE STUDY IN THE US
TAMPA, Fla., April 20, 2024 /PRNewswire/ -- Concept Medical
2024-04-20 01:11
1789
Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success
* To be registered as an official research organization by the National Assembly Secretariat... Expected to become Korea's leading medical think tank * Planning to initiate global multinational clinical projects in digital therapeutics * Establishing a future medical system centered aroun...
2024-04-19 21:00
2342
Concord Medical Files 2023 Annual Report on Form 20-F
BEIJING, April 19, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that it filed its annual report on Form 20-F for t...
2024-04-19 20:31
2484
MGI Tech's DNBSEQ-T20x2* Gene Sequencer Named 2024 Edison Award™ Gold Winner
FORT MYERS, Fla., April 19, 2024 /PRNewswire/ -- MGI Tech
2024-04-19 20:15
1018
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
GAITHERSBURG, Md., April 19, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...
2024-04-19 19:00
3581
GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer
SHANGHAI, April 19, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a mult...
2024-04-19 19:00
1800
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization
SEOUL, South Korea, April 19, 2024 /PRNewswire/ -- South Korea's biotechnology
company Hyundai Bioscience (CEO Oh Sang-gi,www.hyundaibioscience.com
2024-04-19 13:17
1515
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization
SEOUL, South Korea, April 18, 2024 /PRNewswire/ -- South Korea's biotechnology
company Hyundai Bioscience (CEO Oh Sang-gi,www.hyundaibioscience.com
2024-04-19 10:54
1840
EARTHDAY.ORG PARTNERS WITH OAAA TO BRING AWARENESS TO THE DANGERS OF PLASTICS TO HUMAN HEALTH
WASHINGTON, April 19, 2024 /PRNewswire/ -- EARTHDAY.ORG, the global force behind Earth Day, is partnering with the Out of Home Advertising Association of America (OAAA), the leading trade group representing the entire out of home (OOH) advertising industry, for the sixth year in a row! OAAA and ...
2024-04-19 01:45
1578
Milliken & Company Releases 2023 Sustainability Report
Company discloses assessment of sustainability metrics and targets SPARTANBURG, S.C., April 18, 2024 /PRNewswire/ -- Diversified global manufacturer Milliken & Company today released itssixth annual sustainability report that discloses performance against its 2025 Sustainability Goals and 2030 n...
2024-04-18 21:15
1445
Cognivia Secures Strategic 15.5M€ Funding to Empower Drug Development with AI-ML Solutions
Using patient personality traits to pioneer a new era in clinical research. MONT-SAINT-GUIBERT, Belgium, April 18, 2024 /PRNewswire/ -- Cognivia, an innovative AI company dedicated to reshaping pharmaceutical and biotech clinical research through cutting edge AI-ML algorithms, proudly announces a...
2024-04-18 21:00
1858
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
GAITHERSBURG, Md., April 18, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...
2024-04-18 20:00
1188
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
9171
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
8838
Animated Life in Yunnan
2024-04-18 14:00
7827
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7747
IQAX eBL Wins Prestigious APTFF Trade Facilitation Innovation Award 2024
2024-04-18 10:36
3911